Table: Cosmos Pharmaceutical -2025/26 parent results
Jul 13 (Reuters)-
Cosmos Pharmaceutical Corp.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2026 May 31, 2025 May 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.10 trln 1.01 trln
(+8.7 pct) (+4.8 pct)
Operating 42.35 40.39
(+4.8 pct) (+28.3 pct)
Recurring 44.62 43.16
(+3.4 pct) (+25.9 pct)
Net 32.05 30.98
(+3.5 pct) (+26.7 pct)
EPS 404.37 yen 390.83 yen
Ann Div 82.00 yen 70.00 yen 84.00 yen
-Q2 Div 37.50 yen 32.50 yen 42.00 yen
-Q4 Div 44.50 yen 37.50 yen 42.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T